NO971673L - Benzopyran og benzokondenserte forbindelser, deres fremstiling og anvendelse som leukotrien B4 (LTB4) antagonister - Google Patents
Benzopyran og benzokondenserte forbindelser, deres fremstiling og anvendelse som leukotrien B4 (LTB4) antagonisterInfo
- Publication number
- NO971673L NO971673L NO971673A NO971673A NO971673L NO 971673 L NO971673 L NO 971673L NO 971673 A NO971673 A NO 971673A NO 971673 A NO971673 A NO 971673A NO 971673 L NO971673 L NO 971673L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- antagonists
- ltb4
- benzo
- heteroatoms
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000005557 antagonist Substances 0.000 title abstract 3
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 title abstract 3
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 206010015150 Erythema Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 229920001774 Perfluoroether Polymers 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010063837 Reperfusion injury Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 231100000321 erythema Toxicity 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- -1 phenylsulfinyl Chemical group 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/72—Polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32285394A | 1994-10-13 | 1994-10-13 | |
| PCT/IB1995/000397 WO1996011925A1 (en) | 1994-10-13 | 1995-05-26 | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971673D0 NO971673D0 (no) | 1997-04-11 |
| NO971673L true NO971673L (no) | 1997-06-11 |
Family
ID=23256719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971673A NO971673L (no) | 1994-10-13 | 1997-04-11 | Benzopyran og benzokondenserte forbindelser, deres fremstiling og anvendelse som leukotrien B4 (LTB4) antagonister |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5939452A (cs) |
| EP (1) | EP0785935A1 (cs) |
| JP (2) | JP3012339B2 (cs) |
| KR (1) | KR100232340B1 (cs) |
| CN (1) | CN1166834A (cs) |
| AU (1) | AU703557B2 (cs) |
| CA (1) | CA2202056A1 (cs) |
| FI (1) | FI971523A0 (cs) |
| IL (1) | IL115528A0 (cs) |
| MX (1) | MX9702734A (cs) |
| NO (1) | NO971673L (cs) |
| NZ (1) | NZ285154A (cs) |
| TW (1) | TW303364B (cs) |
| WO (1) | WO1996011925A1 (cs) |
| ZA (1) | ZA958596B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2182932A1 (en) * | 1995-08-10 | 1997-02-11 | Koju Watanabe | Chromone derivative, process for preparing same and pharmaceutical composition |
| US6096906A (en) * | 1996-09-16 | 2000-08-01 | Pfizer Inc. | Processes for preparing substituted chromanol derivatives |
| EP0836850A3 (en) * | 1996-10-17 | 2000-11-29 | Pfizer Inc. | Method of preventing allograft rejection |
| EP0963755A3 (en) * | 1998-04-16 | 2001-03-14 | Pfizer Products Inc. | Use of benzopyranes for preventing allograft rejection |
| BR0206771A (pt) * | 2001-01-30 | 2004-02-25 | Pfizer Prod Inc | Processos para a preparação de cidos cromanilbenzóicos |
| AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| EP1457485A1 (en) * | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| JP2005008631A (ja) * | 2003-05-29 | 2005-01-13 | New Industry Research Organization | ベンゾフラン化合物、およびそれを含有してなる医薬組成物 |
| EP1836183A2 (en) | 2004-12-13 | 2007-09-26 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
| BRPI0520097A2 (pt) | 2005-02-25 | 2009-08-25 | Lilly Co Eli | composto ou estereoisÈmeros únicos, misturas de estereoisÈmeros, ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
| US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
| US8242154B2 (en) * | 2008-09-04 | 2012-08-14 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| JP4907746B2 (ja) | 2008-09-11 | 2012-04-04 | ファイザー・インク | ヘテロアリールアミド誘導体およびグルコキナーゼ活性化因子としてのその使用 |
| AP3179A (en) * | 2009-03-11 | 2015-03-31 | Pfizer | Benzofuranyl derivatives used as glucokinase inhibitors |
| PE20171517A1 (es) | 2015-03-13 | 2017-10-20 | Forma Therapeutics Inc | Compuestos y composiciones de alfa-cinamida como inhibidores de hdac 8 |
| WO2017040963A1 (en) | 2015-09-03 | 2017-03-09 | Forma Therapeutics, Inc. | [6,6] fused bicyclic hdac8 inhibitors |
| EP3383389B1 (en) | 2015-11-30 | 2021-04-28 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| EP3383388B1 (en) | 2015-11-30 | 2021-04-14 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| WO2017095725A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl sulfonamides as blt1 antagonists |
| WO2017095724A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl sulfonamides as blt1 antagonists |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1048041A (en) * | 1973-08-11 | 1979-02-06 | Shunsaku Noguchi | Benzalicyclic carboxylic acid derivatives |
| US3953500A (en) * | 1973-08-11 | 1976-04-27 | Takeda Chemical Industries, Ltd. | Benzalicyclic carboxylic acid derivative |
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| CA1320490C (en) * | 1987-01-12 | 1993-07-20 | Darrel M. Gapinski | Anti-inflammatory agents |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| CA2019335C (en) * | 1989-06-27 | 2000-08-01 | Mitoshi Konno | Phenylalkan (en)oic acids |
| US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
| US5073562A (en) * | 1990-05-10 | 1991-12-17 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
| US5051438A (en) * | 1990-05-16 | 1991-09-24 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use |
| US5124350A (en) * | 1990-06-28 | 1992-06-23 | G. D. Searle & Co. | Leukotriene b4 antagonists |
| MX9300312A (es) | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
| JP2813464B2 (ja) * | 1992-01-23 | 1998-10-22 | フアイザー・インコーポレイテツド | ベンゾピラン及び関連ｌｔｂ▲下４▼アンタゴニスト |
-
1995
- 1995-05-26 CN CN95196448A patent/CN1166834A/zh active Pending
- 1995-05-26 KR KR1019970702391A patent/KR100232340B1/ko not_active Expired - Fee Related
- 1995-05-26 US US08/809,727 patent/US5939452A/en not_active Expired - Fee Related
- 1995-05-26 AU AU24165/95A patent/AU703557B2/en not_active Ceased
- 1995-05-26 CA CA002202056A patent/CA2202056A1/en not_active Abandoned
- 1995-05-26 WO PCT/IB1995/000397 patent/WO1996011925A1/en not_active Application Discontinuation
- 1995-05-26 EP EP95918110A patent/EP0785935A1/en not_active Withdrawn
- 1995-05-26 NZ NZ285154A patent/NZ285154A/en unknown
- 1995-05-26 MX MX9702734A patent/MX9702734A/es unknown
- 1995-05-26 JP JP8513056A patent/JP3012339B2/ja not_active Expired - Fee Related
- 1995-10-06 IL IL11552895A patent/IL115528A0/xx unknown
- 1995-10-12 ZA ZA958596A patent/ZA958596B/xx unknown
- 1995-10-13 TW TW084110834A patent/TW303364B/zh active
-
1997
- 1997-04-11 NO NO971673A patent/NO971673L/no not_active Application Discontinuation
- 1997-04-11 FI FI971523A patent/FI971523A0/fi unknown
-
1999
- 1999-02-01 US US09/241,209 patent/US6117874A/en not_active Expired - Fee Related
- 1999-02-15 JP JP11035777A patent/JPH11315062A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR100232340B1 (ko) | 1999-12-01 |
| FI971523A7 (fi) | 1997-04-11 |
| US5939452A (en) | 1999-08-17 |
| CA2202056A1 (en) | 1996-04-25 |
| US6117874A (en) | 2000-09-12 |
| TW303364B (cs) | 1997-04-21 |
| CN1166834A (zh) | 1997-12-03 |
| MX9702734A (es) | 1997-06-28 |
| JPH09511756A (ja) | 1997-11-25 |
| AU2416595A (en) | 1996-05-06 |
| ZA958596B (en) | 1997-04-14 |
| JPH11315062A (ja) | 1999-11-16 |
| WO1996011925A1 (en) | 1996-04-25 |
| IL115528A0 (en) | 1996-01-19 |
| NZ285154A (en) | 1998-11-25 |
| NO971673D0 (no) | 1997-04-11 |
| EP0785935A1 (en) | 1997-07-30 |
| AU703557B2 (en) | 1999-03-25 |
| JP3012339B2 (ja) | 2000-02-21 |
| FI971523A0 (fi) | 1997-04-11 |
| KR970706279A (ko) | 1997-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971673L (no) | Benzopyran og benzokondenserte forbindelser, deres fremstiling og anvendelse som leukotrien B4 (LTB4) antagonister | |
| NO971672L (no) | Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister | |
| KR100765051B1 (ko) | 신규 티아졸로(4,5-ｄ)피리미딘 화합물 | |
| US5124331A (en) | 3,4-dihydrothieno[2,3-d]pyrimidine compounds and their pharmaceutical use | |
| US7084148B2 (en) | Substituted pyrimidines as selective cyclooxygenase-2 inhibitors | |
| JP2018104434A (ja) | Ｔｎａｐ阻害剤としてのスルホンアミド化合物およびその使用 | |
| KR20110007235A (ko) | 시르투인 조절제로서의 퀴놀린 및 관련 유사체 | |
| ES2524314T3 (es) | Derivados del ácido fenoxicroman carboxílico sustituidos en 6 | |
| WO2002070509A2 (en) | Antagonists of mcp-1 function and methods of use thereof | |
| JPWO2013187466A1 (ja) | 分岐鎖アルキルヘテロ芳香環誘導体 | |
| JPH06172339A (ja) | 新規ベンゾピラン化合物、その製造法およびこれらを含む医薬組成物 | |
| AU713573B2 (en) | Chroman derivatives | |
| KR930005998A (ko) | 비사이클릭 카복실산 유도체 | |
| EP0519996A1 (en) | Imidazoles | |
| WO2001058907A1 (en) | Thiazolopyrimidines and their use as modulators of chemokine receptor activity | |
| AU2014312756B2 (en) | Novel aromatic compound and use thereof | |
| JPH10316641A (ja) | カルボン酸誘導体 | |
| PT984963E (pt) | Compostos novos | |
| EP1474140A1 (en) | 2-oxazolamines and their use as 5-ht2b receptor antagonists | |
| JPH0848671A (ja) | ベンズイミダゾール誘導体 | |
| DK458283D0 (da) | Fremgangsmade til fremstilling af phenylindenderivater eller syreadditionssalte deraf | |
| US5236935A (en) | Benzopyran derivatives and processes for the preparation thereof | |
| CN101838245B (zh) | 喹唑啉衍生物或其药用盐、制备方法和用途 | |
| JP2011502957A (ja) | アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物 | |
| RU2312859C2 (ru) | Производные 1,3,5-триазина, фармацевтическая композиция на их основе и их применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |